Astrazeneca Pharma India Ltd (ASTRAZEN) 52 Week Low Streak: 8th Day Near Yearly Low

Astrazeneca Pharma India Ltd 52 Week Low Streak has now stretched to its eighth consecutive session, with the stock trading within 2% of its 52-week low across the entire run. Over that stretch, Astrazeneca Pharma India Ltd 52 Week Low Streak has seen a cumulative decline of 9.18%, with the latest trough at Rs 5,660 and the stock last traded at Rs 5,710. The latest Univest data confirms the repeated-low pattern, but it does not establish any company-specific cause for the continued weakness.

Astrazeneca Pharma India Ltd Share Price was last traded at Rs 5,710, compared with the previous close of Rs 5,704.05, after opening at Rs 5,726 and touching a high of Rs 5,726 before moving to a low of Rs 5,660. Astrazeneca Pharma India Ltd 52 Week Low Streak matters because it shows a repeated price breakdown rather than a one-off slip, and the pattern is more relevant for readers tracking persistence than for those focusing only on a single intraday move. The company’s market capitalisation stood at Rs 14,260.13 crore.

Astrazeneca Pharma India Ltd 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 5,710
Previous Close	Rs 5,704.05
Today's Move	+Rs 5.95 (+0.1%)
Open	Rs 5,726
High	Rs 5,726
Low	Rs 5,660
Market Capitalisation	Rs 14,260.13 crore

Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 5,710 versus the previous close of Rs 5,704.05, a rise of 0.1%. The stock opened at Rs 5,726, reached a high of Rs 5,726, touched a low of Rs 5,660.

Astrazeneca Pharma India Ltd Share Price Today showed a mild intraday rise of Rs 5.95, or 0.1%, versus the previous close, but that small change does little to alter the broader weakness reflected in the eight-session streak. Astrazeneca Pharma India Ltd Share Price moved between Rs 5,660 and Rs 5,726 during the period under review, with the current price sitting close to the lower end of that range. The stock opened at Rs 5,726 and immediately stayed near the upper end of the day’s band before easing back toward the low, which keeps attention on the repeated proximity to its one-year trough.

For readers following Astrazeneca Pharma India Ltd Stock News, the important point is not the day’s narrow movement alone but the persistence of the near-low pattern. Astrazeneca Pharma India Ltd Share Price Update shows the stock has been trading close to the same floor for multiple sessions, which makes Astrazeneca Pharma India Ltd Stock Performance more meaningful when viewed across the full streak. Astrazeneca Pharma India Ltd Market Cap stood at Rs 14,260.13 crore, placing the move in context for investors tracking Astrazeneca Pharma India Ltd NSE and Astrazeneca Pharma India Ltd BSE price behaviour during a continued decline. The repeated low pattern also places the stock in focus among Stocks At One Year Low Today and Stocks Hitting 52 Week Lows.

What the Repeated 52-Week Lows Show

Astrazeneca Pharma India Ltd 52 Week Low Streak has now become an eight-session pattern, and that is the central signal in the data. Astrazeneca Pharma India Ltd 52 Week Low For eighth consecutive session suggests the market has been willing to keep valuing the stock near the same yearly floor rather than moving away from it. The current 52-week low is also the clearest anchor for the streak: the latest trough at Rs 5,660 is the level around which the stock has repeatedly hovered, while the full streak has produced a cumulative decline of 9.18%.

This is why Astrazeneca Pharma India Ltd Consecutive 52 Week Low deserves more attention than a single-day print. Astrazeneca Pharma India Ltd New One Year Low is not the right framing here unless the stock actually breaks below the prior trough, which the latest Univest figures do not show. What the numbers do show is a sustained weakness that has persisted across multiple trading sessions. For people searching Astrazeneca Pharma India Ltd Back To Back 52 Week Lows, the answer is straightforward: the pattern is confirmed, but the cause is not. The latest Univest data identifies the price behaviour, not the reason behind it.

In that sense, Astrazeneca Pharma India Ltd 52 Week Low Streak is best read as a continuation story. The stock has not moved far enough away from the one-year low to suggest that the pressure has been reversed. Instead, the repeated trading near the floor keeps the focus on whether the downside has stabilised or is still developing. For anyone following 52 Week Low Stocks, the key metric is the streak length itself, because the persistence of the pattern often matters more than a single-day change.

Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 14,260.13 crore
P/E Ratio	84.07x
P/B Ratio	15.77x
ROE	23.02%
ROCE	31.24%
EPS	Rs 67.85
Book Value Per Share	Rs 361.68
Dividend Yield	0.63%

Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P/E 84.07x, P/B 15.77x, ROE 23.02%, ROCE 31.24%. These figures provide context only and are not a buy or sell signal.

Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 14,260.13 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 84.07x, P/B at 15.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.63%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.02x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	84.07x
Benchmark Median P/E	27.02x
Benchmark Average P/E	39.77x
Benchmark P/E Range	0x to 678.22x
Company P/B Ratio	15.77x
Benchmark Median P/B	2.79x
Company ROE	23.02%
Benchmark Median ROE	11.48%
Company ROCE	31.24%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 14,260.13 crore
Benchmark Median Market Cap	Rs 803.77 crore

Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 84.07x, which is above the benchmark median of 27.02x, a difference of +211.14%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.48%, a difference of +100.52%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.28%, a difference of +135.24%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Concord Biotech Ltd.	CONCORDBIO	14,198.51	50.53	6.71	13.54	18.04
Marksans Pharma Ltd.	MARKSANS	14,741.42	27	4.39	15.31	21.1
Sudeep Pharma Ltd.	SUDEEPPHRM	13,179.41	68.76	13.59	25.37	28.5
Jubilant Pharmova Ltd.	JUBLPHARMA	15,517.96	42.17	2.08	5.97	8.69
Akums Drugs & Pharmaceuticals Ltd.	AKUMS	12,939.36	42.4	3.62	8.06	14.77

Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 84.07x compared with the displayed peer median of 42.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 13.54% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 18.04%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 14,260.13 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching

• Astrazeneca Pharma India Ltd 52 Week Low Streak has run for eight consecutive sessions, which keeps the yearly low pattern in focus.
• Astrazeneca Pharma India Ltd Share Price remains close to the 52-week trough, so small intraday moves are not yet changing the wider trend.
• Astrazeneca Pharma India Ltd Fundamental Analysis shows strong return ratios, even though valuation stays rich versus peers.
• Astrazeneca Pharma India Ltd Market Cap is large enough to keep the stock on the radar of readers following Healthcare and Pharmaceuticals & Drugs names.
• Investors watching Stocks At One Year Low Today will want to see whether the pattern shifts away from the current floor.

About the Company

Astrazeneca Pharma India Ltd operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s current stock discussion is being shaped by Astrazeneca Pharma India Ltd 52 Week Low Streak, while the business profile is still defined by the higher return ratios visible in the latest Univest figures. Astrazeneca Pharma India Ltd Share Price Today is therefore being read through both a market lens and a business-performance lens.

The company’s market capitalisation stood at Rs 14,260.13 crore, and its valuation, return ratios and dividend yield are all available for readers comparing Astrazeneca Pharma India Ltd Stock Analysis with other listed pharmaceutical names. In this article, the focus remains on the repeated near-low pattern and what it says about price behaviour across the streak.

Frequently Asked Questions

How long has Astrazeneca Pharma India Ltd traded near its 52-week low?

Ans. Astrazeneca Pharma India Ltd 52 Week Low Streak has now extended to eight consecutive sessions. The stock has stayed within 2% of its 52-week low across that period, which makes the pattern more persistent than a one-day move.

What is the cumulative move across the streak?

Ans. Across the full Astrazeneca Pharma India Ltd 52 Week Low Streak, the stock has recorded a cumulative decline of 9.18%. That figure is the clearest summary of the repeated weakness across the eight-session run.

Has the stock set a new 52-week low today?

Ans. No new 52-week low is confirmed by the latest Univest figures. Astrazeneca Pharma India Ltd Share Price has remained close to its yearly trough, but the data provided shows proximity to the low rather than a fresh break below it.

Does the data confirm a company-specific reason for the decline?

Ans. No. The latest Univest data confirms the repeated low pattern, but it does not establish a company-specific cause for the continued weakness. The price behaviour is clear; the reason is not.

How does valuation compare with peers?

Ans. Astrazeneca Pharma India Ltd Share Price is trading at a P/E of 84.07 and P/B of 15.77, which are above the latest Univest industry medians. That places the stock at a richer valuation than many peer names in the healthcare list.

What should investors monitor next?

Ans. Investors can track whether Astrazeneca Pharma India Ltd Share Price moves away from the 52-week trough, whether the repeated-low pattern continues, and whether valuation remains elevated relative to peers. Those are the key facts available from the latest Univest data.

Why does the streak matter more than one day’s move?

Ans. A one-day change can be small even when the broader trend is weak. Astrazeneca Pharma India Ltd 52 Week Low Streak shows that the stock has stayed near its yearly floor for eight sessions, which gives a more complete view.

Track Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price on Univest

Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.